There are a lot of very exciting papers coming out about cancer neuroscience, and the anti-tumor potential of modulating neurotransmission at brain-glioma synapses and other points of interaction or connection in the nervous system components of the tumor microenvironment. In addition to Dr. J...
Answer from: Radiation Oncologist at Academic Institution
In this recent publication from the Brigham and Women's Hospital and UCSF, it was reported that patients who received gabapentin in the post-operative period benefitted with an increase in overall median survival by approximately 4 months: "Median overall survival in patients receiving postoperative...
Answer from: Radiation Oncologist at Academic Institution
While this study brings up an interesting point, I’m not convinced that gabapentin should be added to glioblastoma treatment regimens based on these findings. After decades of research and innumerable glioblastoma trials, including those beyond TMZ, we haven’t seen significant progress w...
Comments
Radiation Oncologist at West Virginia University A 4-month median OS benefit from gabapentin is bet...